نتائج البحث - "Jean-luc Raoul"

1

المؤلفون: Helena Pereira, Mohamed Bouattour, Marco D. Burgio, Eric Assenat, Jules Grégory, Jean-Pierre Bronowicki, Gilles Chatellier, Valérie Vilgrain, Elisabeth Delhom-Christol, Marjolène Fourcade, Boris Guiu, Alina Diana Ilonca, Julie Lonjon, Georges-Philippe Pageaux, Mohamed Abdel-Rehim, Wassim Allaham, Laurent Castera, Arnaud Dieudonné, Rachida Lebtahi, Maxime Ronot, Annie Sibert, Hélène Chor, Julie Devictor, Hélène Barraud, Christophe Bazin, Laetitia Imbert, Valérie Laurent, Elodie Mathias, Carine Chagneau-Derrode, Christelle Gallais, Rémy Perdrisot, Christine Silvain, Jean Pierre Tasu, Patrick Borentain, Bardia Farman, René Gerolami, Olivier Mundler, Jean-Francois Seitz, Vincent Vidal, Christophe Aubé, Francis Bouchet, Antoine Bouvier, Olivier Couturier, Frédéric Oberti, Laurent Vervueren, Isabelle Brenot-Rossi, Julien Darreon, Jean Luc Raoul, Anthony Sarran, Julia Chalaye, Charlotte Costentin, Emmanuel Itti, Hicham Kobeiter, Alain Luciani, Hélène Masset, René Adam, Maïté Lewin, Didier Samuel, Julien Edeline, Etienne Garin, Sophie Laffont, Yan Rolland, Isabelle Archambeaud, Thomas Carlier, Thomas Eugene, Eric Frampas, Christophe Cassinotto, Martine Guyot, Jean-Baptiste Hiriart, Bruno Lapuyade, Karine Tendero, Julien Vergniol, Philippe Bachellier, Julien Détour, Bernard Duclos, Michel Greget, Francois Habersetzer, Alessio Imperiale, Elise Enderlin, Philippe Merle, Agnès Rode, Julie Morvan, Eric Nguyen-Khac, Antoine Talbot, Thierry Yzet, Guillaume Baudin, Patrick Chevallier, Abakar Mahamat, Fabien Maurel, Thierry Piche, Micheline Razzouk, Patrick Hillon, Romaric Loffroy, Michel Toubeau, Julie Vincent, Jean-Marc Vrigneaud, Gabriele Barabino, Nadia Bouarioua, Muriel Cuilleron, Marie Ecochard, Nathalie Prevot-Bitot, Evelyne Rousset, Vincent Leroy, Ghislaine Reboulet, Julie Roux, Christian Sengel, Valérie Bourcier, Nathalie Ganne-Carrie, Olivier Seror, Sylvie Costo, Thông Dao, Cédric Desmonts, Jean-Pierre Pelage, Didier Defez, Jérôme Dumortier, Francesco Giammarile, Pierre-Jean Valette, Michela Bernardini, Nadia Ghazar, Olivier Pellerin, Julien Taieb, Pierre Weinmann, Alexandra Heurgue-Berlot, Claude Marcus, Daniele Sommacale, Maria-Angéla Castilla-Lièvre, Aurélie Forbes, Sophie Maitre, Lysiane Marthey

المساهمون: CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPC), Centre de recherche sur l'Inflammation (CRI (UMR_S_1149 / ERL_8252 / U1149)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPC), Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB)

المصدر: European Journal of Cancer
European Journal of Cancer, Elsevier, 2021, 154, pp.46-56. ⟨10.1016/j.ejca.2021.05.032⟩

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::813a4496fe7c63c5833e2c6c0dfdee24Test
https://doi.org/10.1016/j.ejca.2021.05.032Test

2

Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort

المؤلفون: Xavier Adhoute, Hervé Perrier, P. Cassagneau, Paul Castellani, Valérie Oules, Jean-Pierre Bronowicki, Olivia Pietri, Jean-Luc Raoul, Patrick Beaurain, Olivier Monnet, Cyrille Muller, B. Pol, Guillaume Penaranda, Marc Bourlière, Olivier Bayle

المصدر: European Journal of Gastroenterology & Hepatology. 31:1414-1423

مصطلحات موضوعية: Male, medicine.medical_specialty, Carcinoma, Hepatocellular, Contrast Media, Antineoplastic Agents, Gastroenterology, Cohort Studies, Neoplasms, Multiple Primary, 03 medical and health sciences, Ethiodized Oil, 0302 clinical medicine, Internal medicine, medicine, Humans, Aspartate Aminotransferases, Progression-free survival, Chemoembolization, Therapeutic, Stage (cooking), Survival rate, Aged, Epirubicin, Proportional Hazards Models, Retrospective Studies, Hepatology, business.industry, Liver Neoplasms, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, Magnetic Resonance Imaging, Progression-Free Survival, BCLC Stage, Tumor Burden, Survival Rate, Treatment Outcome, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Lipiodol, Female, 030211 gastroenterology & hepatology, France, alpha-Fetoproteins, Tomography, X-Ray Computed, business, Liver cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d88340b6aff92a39c97d9692dc73ed6Test
https://doi.org/10.1097/meg.0000000000001420Test

3

Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors

المؤلفون: Jean-Luc Raoul, Nathalie Charrier, Sandrine Oziel-Taieb, Gerard Cavaglione, Flora Poizat, L. Mineur, Gilles Piana, Christophe Zemmour, Patricia Niccoli

المساهمون: Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Institut Sainte Catherine [Avignon], Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Malbec, Odile

المصدر: Anticancer Research
Anticancer Research, 2021, 41 (4), pp.2071-2078. ⟨10.21873/anticanres.14977⟩

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Organoplatinum Compounds, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Leucovorin, Neuroendocrine tumors, Young Adult, FOLFOX, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Intestinal Neoplasms, enteropancreatic neuroendocrine tumors, medicine, Humans, Chemotherapy, In patient, Neoplasm Metastasis, metastases, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Significant difference, oxaliplatin, Retrospective cohort study, General Medicine, Middle Aged, medicine.disease, Primary tumor, Survival Analysis, digestive system diseases, Oxaliplatin, [SDV] Life Sciences [q-bio], Pancreatic Neoplasms, Neuroendocrine Tumors, Treatment Outcome, Female, Fluorouracil, France, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88af78f8fb872e2f7d049cd0ba32942dTest
https://www.hal.inserm.fr/inserm-03649596/file/2071.full.pdfTest

4

FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial

المصدر: European Journal of Cancer. 115:97-106

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Time Factors, Esophageal Neoplasms, Organoplatinum Compounds, medicine.medical_treatment, Leucovorin, Rilotumumab, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Gastroenterology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, FOLFOX, Stomach Neoplasms, Interquartile range, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Panitumumab, Aged, EGFR inhibitors, Chemotherapy, business.industry, Middle Aged, Progression-Free Survival, Oxaliplatin, 030104 developmental biology, Oncology, Fluorouracil, 030220 oncology & carcinogenesis, Disease Progression, Female, France, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16942ea1fceea67feaa68600fbfeb033Test
https://doi.org/10.1016/j.ejca.2019.04.020Test

5

Patients with resectable pancreatic adenocarcinoma: A 15-years single tertiary cancer center study of laparotomy findings, treatments and outcomes

المؤلفون: Jacques Ewald, Jean-Robert Delpero, Laurence Moureau-Zabotto, Flora Poizat, Jean-Luc Raoul, Olivier Turrini, Marine Gilabert

المصدر: Surgical Oncology. 27:619-624

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e430675900bb996a0efa2109621b6293Test
https://doi.org/10.1016/j.suronc.2018.07.014Test

6

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study

المؤلفون: Denis Smith, Côme Lepage, Pascal Artru, Julien Taieb, Laetitia Dahan, David Tougeron, Carole Monterymard, Christelle De La Fouchardiere, Simon Pernot, Rosine Guimbaud, Jean-Luc Raoul, David Sefrioui, for Ffcd Debiri investigators, Olivier Pellerin, Jean-Louis Jouve

المصدر: British Journal of Cancer

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Organoplatinum Compounds, Cancer therapy, Colorectal cancer, Leucovorin, Phases of clinical research, Irinotecan, Gastroenterology, Drug Administration Schedule, Article, 030218 nuclear medicine & medical imaging, Resection, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Intra arterial, Humans, In patient, Chemoembolization, Therapeutic, Objective response, Aged, Systemic chemotherapy, business.industry, Liver Neoplasms, Middle Aged, medicine.disease, Combined Modality Therapy, Survival Analysis, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Drug delivery, Female, Fluorouracil, business, Colorectal Neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8712675ee06e95e857ce17a8bed494Test
https://pubmed.ncbi.nlm.nih.gov/32507854Test

7

Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals

المؤلفون: Floriane Sellier, Marc Bourlière, B. Pol, Manuela Campanile, Patrick Beaurain, Hervé Perrier, Olivier Bayle, Xavier Adhoute, Valérie Oules, G. Lefolgoc, Guillaume Penaranda, Jean-Luc Raoul, Paul Castellani, Olivier Monnet

المصدر: European Journal of Gastroenterology & Hepatology. 30:368-375

مصطلحات موضوعية: Liver Cirrhosis, Male, medicine.medical_specialty, Carcinoma, Hepatocellular, Cirrhosis, Sustained Virologic Response, Hepatitis C virus, medicine.disease_cause, Antiviral Agents, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Humans, Medicine, Stage (cooking), Aged, Neoplasm Staging, Hepatology, business.industry, Liver Neoplasms, Case-control study, Hepatitis C, Hepatitis C, Chronic, Middle Aged, medicine.disease, digestive system diseases, Case-Control Studies, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Disease Progression, Female, 030211 gastroenterology & hepatology, Liver function, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3824f7723baba243b7f509258f76f664Test
https://doi.org/10.1097/meg.0000000000001082Test

8

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response

المؤلفون: Neal J. Meropol, Jorge Barriuso, Juan W. Valle, Heinz-Josef Lenz, Catherine Lombard-Bohas, Angela Lamarca, Matthew H. Kulke, Jean-Luc Raoul, James Posey, Sandrine Faivre, Ivan Borbath, Eric Raymond

المساهمون: UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie, UCL - (SLuc) Service de gastro-entérologie

المصدر: British Journal of Cancer
Lamarca, A, Barriuso, J, Kulke, M H, Ivan, B, Lenz, H-J, Raoul, J-L, Meropol, N J, Lombard-Bohas, C, Posey, J, Faivre, S, Raymond, E & Valle, J 2017, ' Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response ', British Journal of Cancer . https://doi.org/10.1038/bjc.2017.402Test
The British journal of cancer, Vol. 118, p. 181-188 (2018)

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, sunitinib, Phases of clinical research, Efficacy, 03 medical and health sciences, Clinical Trials, Phase II as Topic, 0302 clinical medicine, Internal medicine, neuroendocrine tumour, medicine, Humans, pancreas, Progression-free survival, Pancreas, Response Evaluation Criteria in Solid Tumors, Survival analysis, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Manchester Cancer Research Centre, business.industry, Sunitinib, ResearchInstitutes_Networks_Beacons/mcrc, Hazard ratio, radiological response, Middle Aged, Survival Analysis, Progression-Free Survival, Pancreatic Neoplasms, Neuroendocrine Tumors, Treatment Outcome, 030104 developmental biology, medicine.anatomical_structure, RECIST, Clinical Trials, Phase III as Topic, 030220 oncology & carcinogenesis, Clinical Study, Female, business, progression-free survival, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52bc91b1de5ac4ca75903c889fab03b7Test
https://doi.org/10.1038/bjc.2017.402Test

9

Prognostic value of PDL1 expression in pancreatic cancer

المؤلفون: Flora Poizat, David Jérémie Birnbaum, Pascal Finetti, Jean-Robert Delpero, Vincent Moutardier, Marine Gilabert, Alexia Lopresti, Olivier Turrini, Daniel Birnbaum, François Bertucci, Jean-Luc Raoul, Emilie Mamessier

المساهمون: Cancérologie expérimentale, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Department of Surgical Oncology, Université de la Méditerranée - Aix-Marseille 2, Aix-Marseille Université - Faculté de médecine (AMU MED), Aix Marseille Université (AMU), Inserm, Institut Paoli-Calmettes, and SIRIC (INCa-DGOS-Inserm 6038 grant)., mamessier, emilie, Assistance Publique - Hôpitaux de Marseille (APHM)

المصدر: Oncotarget
Oncotarget, Impact journals, 2016, 7 (44), ⟨10.18632/oncotarget.11685⟩
Oncotarget, 2016, 7 (44), ⟨10.18632/oncotarget.11685⟩
Oncotarget, 2016, 7 (44), pp.71198-71210. ⟨10.18632/oncotarget.11685⟩

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pathology, medicine.medical_specialty, Gastrointestinal Stromal Tumors, T-Lymphocytes, Lymphocyte, pancreatic cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer, survival, immune response, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Immune system, Breast cancer, [SDV.CAN] Life Sciences [q-bio]/Cancer, Downregulation and upregulation, PDL1, Pancreatic cancer, expression, medicine, Humans, Lymph node, Aged, Aged, 80 and over, Antigen Presentation, business.industry, FOXP3, Cancer, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, Middle Aged, Prognosis, medicine.disease, 3. Good health, Pancreatic Neoplasms, 030104 developmental biology, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Cancer research, Female, [SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy, business, Research Paper

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e38ea484ce33727ab8c3b7d1438c606Test
https://doi.org/10.18632/oncotarget.11685Test

10

Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence

المؤلفون: Olivier Kerdraon, Judith Raimbourg, Valéria De Franco, Solène Joseph, Gérard Lorimier, Olivier Capitain, Veronique Guerin-Meyer, Valérie Verriele, Jean-Luc Raoul, Frédéric Dumont, Hélène Senellart, Sandrine Hiret, Romuald Wernert, Emilie Thibaudeau, Loïc Campion

المصدر: Surgical oncology. 32

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Colorectal cancer, Population, Patient characteristics, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective Studies, education, Peritoneal Neoplasms, Aged, education.field_of_study, business.industry, Incidence (epidemiology), Systematic lymphadenectomy, Cancer, Perioperative, Hyperthermia, Induced, Middle Aged, medicine.disease, Prognosis, Adenocarcinoma, Mucinous, Combined Modality Therapy, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Lymphatic Metastasis, Conventional PCI, 030211 gastroenterology & hepatology, Surgery, Female, Neoplasm Recurrence, Local, business, Colorectal Neoplasms, Carcinoma, Signet Ring Cell, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e4b99902c046c63d4f716aa192ff06Test
https://pubmed.ncbi.nlm.nih.gov/31707314Test

تنقيح النتائج